Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > NY Providers

Dr. Massimo Cristofanilli, MD

Accepting New Patients

(Massimo Cristofanilli, M.D.)

(No ratings)

Specializes in: Medical Oncology and Hematology (Blood Disorders)

Sapienza University of Rome (1986)

Professional interests include: cancer, clinical trials, cancer immunotherapy, and more.

1283 York Avenue 4th Floor
New York, NY 10065

(646) 962-2330

Dr. Massimo Cristofanilli, MD is a medical oncologist in New York, NY specializing in medical oncology and hematology (blood disorders). He graduated from Sapienza University of Rome in 1986 and has 40 years of experience. Dr. Massimo Cristofanilli, MD is affiliated with NewYork-Presbyterian, Weill Cornell Medicine and Breast Center at Weill Cornell Medicine.

Office Locations

1283 York Avenue 4th Floor
New York, NY 10065

open_in_new

528 E 68th Street
New York, NY 10065

open_in_new

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

doctor visit	65

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Massimo Cristofanilli, MD treated as a medical oncologist in New York, NY during 2013 were hospital care and inpatient care.

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

doctor visit	117
hospital care	58
inpatient care	58

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Massimo Cristofanilli, MD.

**Age**
From 65 to 74	22
From 75 to 84	0
85 and over	0
Less than 65	13

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2013

Hypertension	60
High Cholesterol	47
Stroke	0
Ischemic Heart Disease	34
Depression	0
Chronic Kidney Disease	23
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	28
Dementia	0
Cancer	75

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

doctor visit	232

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Massimo Cristofanilli, MD.

**Ethnicity**
Non-Hispanic White	52
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	40
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2014

Hypertension	51
High Cholesterol	42
Stroke	0
Ischemic Heart Disease	22
Depression	19
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	22
Dementia	0
Cancer	75

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

doctor visit	217

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Massimo Cristofanilli, MD.

**Ethnicity**
Non-Hispanic White	94
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	64
From 75 to 84	0
85 and over	0
Less than 65	34

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2015

Hypertension	47
High Cholesterol	43
Stroke	0
Ischemic Heart Disease	0
Depression	33
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	25
Dementia	0
Cancer	75

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Massimo Cristofanilli, MD treated as a medical oncologist in New York, NY during 2016 were blood draw, chemotherapy, biological response modifier (BRM) therapy and minimally invasive procedures.

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

biological response modifier (BRM) therapy	53
blood draw	56
chemotherapy	53
doctor visit	100
hospital care	17
inpatient care	17
minimally invasive procedures	53

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Massimo Cristofanilli, MD.

**Gender**
Male	15
Female	93

**Ethnicity**
Non-Hispanic White	76
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	56
From 75 to 84	0
85 and over	0
Less than 65	26

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2016

Hypertension	56
High Cholesterol	37
Stroke	0
Ischemic Heart Disease	21
Depression	19
Chronic Kidney Disease	33
Asthma	18
Osteoperosis	10
Atrial Fibrilation	0
Heart Failure	11
Chronic Obstructive Pulmonary Disease	16
Diabetes	24
Dementia	0
Cancer	75

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Massimo Cristofanilli, MD treated as a medical oncologist in New York, NY during 2017 were chemotherapy, biological response modifier (BRM) therapy, minimally invasive procedures and hormone therapy.

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

biological response modifier (BRM) therapy	86
chemotherapy	86
doctor visit	139
hormone therapy	24
minimally invasive procedures	86

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Massimo Cristofanilli, MD.

**Gender**
Male	24
Female	159

**Ethnicity**
Non-Hispanic White	123
Black	36
Hispanic	12
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	94
From 75 to 84	46
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2017

Hypertension	56
High Cholesterol	30
Stroke	0
Ischemic Heart Disease	25
Depression	23
Chronic Kidney Disease	28
Asthma	9
Osteoperosis	15
Atrial Fibrilation	0
Heart Failure	14
Chronic Obstructive Pulmonary Disease	11
Diabetes	28
Dementia	0
Cancer	75

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Massimo Cristofanilli, MD treated as a medical oncologist in New York, NY during 2018 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hormone therapy.

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

biological response modifier (BRM) therapy	101
chemotherapy	101
doctor visit	259
hormone therapy	26
minimally invasive procedures	115

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Massimo Cristofanilli, MD.

**Gender**
Male	21
Female	185

**Ethnicity**
Non-Hispanic White	132
Black	44
Hispanic	17
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	123
From 75 to 84	39
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2018

Hypertension	53
High Cholesterol	37
Stroke	0
Ischemic Heart Disease	22
Depression	27
Chronic Kidney Disease	26
Asthma	9
Osteoperosis	17
Atrial Fibrilation	0
Heart Failure	11
Chronic Obstructive Pulmonary Disease	9
Diabetes	22
Dementia	10
Cancer	75

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Massimo Cristofanilli, MD treated as a medical oncologist in New York, NY during 2019 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hospital care.

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

biological response modifier (BRM) therapy	191
chemotherapy	191
doctor visit	305
hormone therapy	40
hospital care	50
inpatient care	50
minimally invasive procedures	215

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Massimo Cristofanilli, MD.

**Gender**
Male	36
Female	222

**Ethnicity**
Non-Hispanic White	182
Black	35
Hispanic	16
Asian	13
Other	12
Native American	0

**Age**
From 65 to 74	156
From 75 to 84	58
85 and over	13
Less than 65	31

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2019

Hypertension	49
High Cholesterol	34
Stroke	4
Ischemic Heart Disease	22
Depression	22
Chronic Kidney Disease	25
Asthma	0
Osteoperosis	19
Atrial Fibrilation	6
Heart Failure	14
Chronic Obstructive Pulmonary Disease	10
Diabetes	20
Dementia	8
Cancer	75

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Massimo Cristofanilli, MD treated as a medical oncologist in New York, NY during 2020 were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hormone therapy.

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

biological response modifier (BRM) therapy	274
chemotherapy	274
doctor visit	354
hormone therapy	79
hospital care	75
inpatient care	75
minimally invasive procedures	294

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Massimo Cristofanilli, MD.

**Gender**
Male	40
Female	233

**Ethnicity**
Non-Hispanic White	191
Black	41
Hispanic	20
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	166
From 75 to 84	54
85 and over	14
Less than 65	39

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2020

Hypertension	49
High Cholesterol	36
Stroke	0
Ischemic Heart Disease	20
Depression	23
Chronic Kidney Disease	28
Asthma	9
Osteoperosis	17
Atrial Fibrilation	6
Heart Failure	16
Chronic Obstructive Pulmonary Disease	7
Diabetes	18
Dementia	8
Cancer	74

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Massimo Cristofanilli, MD treated as a medical oncologist in New York, NY during 2021 were chemotherapy, biological response modifier (BRM) therapy, minimally invasive procedures and hormone therapy.

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

biological response modifier (BRM) therapy	156
blood draw	13
chemotherapy	156
doctor visit	408
hormone therapy	100
hospital care	49
inpatient care	49
minimally invasive procedures	156

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Massimo Cristofanilli, MD.

**Gender**
Male	29
Female	235

**Ethnicity**
Non-Hispanic White	193
Black	34
Hispanic	15
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	148
From 75 to 84	62
85 and over	18
Less than 65	36

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2021

Hypertension	48
High Cholesterol	39
Stroke	0
Ischemic Heart Disease	23
Depression	21
Chronic Kidney Disease	26
Asthma	6
Osteoperosis	20
Atrial Fibrilation	7
Heart Failure	13
Chronic Obstructive Pulmonary Disease	9
Diabetes	18
Dementia	6
Cancer	75

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

doctor visit	219

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Massimo Cristofanilli, MD.

**Ethnicity**
Non-Hispanic White	47
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	38
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2022

Hypertension	48
High Cholesterol	60
Stroke	0
Ischemic Heart Disease	0
Depression	28
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	28
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	22
Dementia	0
Cancer	75

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

doctor visit	587

2023 Medicare Patient Data

Information about Medicare patients treated by Dr. Massimo Cristofanilli, MD.

**Ethnicity**
Non-Hispanic White	104
Black	0
Hispanic	0
Asian	0
Other	13
Native American	0

**Age**
From 65 to 74	74
From 75 to 84	41
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2023

Hypertension	63
High Cholesterol	69
Stroke	0
Ischemic Heart Disease	16
Depression	23
Chronic Kidney Disease	15
Asthma	10
Osteoperosis	34
Atrial Fibrilation	9
Heart Failure	14
Chronic Obstructive Pulmonary Disease	11
Diabetes	23
Dementia	0
Cancer	75

Medicare Procedure and Patient Information

2024 Medicare Procedure Volume

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

doctor visit	561

2024 Medicare Patient Data

Information about Medicare patients treated by Dr. Massimo Cristofanilli, MD.

**Ethnicity**
Non-Hispanic White	110
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	68
From 75 to 84	42
85 and over	12
Less than 65	11

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2024

Hypertension	56
High Cholesterol	71
Stroke	9
Ischemic Heart Disease	20
Depression	26
Chronic Kidney Disease	15
Asthma	9
Osteoperosis	34
Atrial Fibrilation	14
Heart Failure	18
Chronic Obstructive Pulmonary Disease	14
Diabetes	26
Dementia	0
Cancer	75

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2024

Volume of procedures performed by Dr. Massimo Cristofanilli, MD for Medicare patients.

The highest averages for the top procedures that Dr. Massimo Cristofanilli, MD treated as a medical oncologist in New York, NY were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hormone therapy.

biological response modifier (BRM) therapy	143
blood draw	34
chemotherapy	143
doctor visit	274
hormone therapy	53
hospital care	49
inpatient care	49
minimally invasive procedures	153

Average Medicare Patient Data From 2012 - 2024

Information about Medicare patients treated by Dr. Massimo Cristofanilli, MD.

**Gender**
Male	12
Female	86

**Ethnicity**
Black / African American	14
Asian / Pacific Islander	1
Non-Hispanic White	100
Hispanic	6
Native American / Alaskan Native	0
Other	1

**Age**
75 to 84	26
85 and over	4
Less than 65	14
65 to 74	80

Average of Total of Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD From 2012 - 2024

The highest averages of the most common conditions of Medicare patients that Dr. Massimo Cristofanilli, MD treated were cancer, hypertension, high cholesterol and diabetes.

Hypertension	48
High Cholesterol	41
Stroke	1
Ischemic Heart Disease	17
Depression	20
Chronic Kidney Disease	16
Asthma	5
Osteoporosis	14
Heart Failure	8
Chronic Obstructive Pulmonary Disease	6
Diabetes	21
Atrial Fibrillation	3
Cancer	69
Dementia	2

Education & Training

Dr. Massimo Cristofanilli, MD graduated from Sapienza University of Rome in 1986. He is certified by the American Board of Internal Medicine (Medical Oncology) and has a state license in Illinois.

Medical School: Sapienza University of Rome (1986)

Board Certification: American Board of Internal Medicine (Medical Oncology)

Licensed In: Illinois

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Massimo Cristofanilli, MD appears to accept the following insurance providers: Aetna PPO, Health Insurance Plan of New York (HIP), United Healthcare Medicare, Aetna HMO, Aetna Medicare, EmblemHealth, Fidelis Care, WellCare, Medicare Advantage, Affinity Health Plan, GHI CBP, United Healthcare, Aetna, Oxford Health Plans, Medicare, Healthfirst, Medicaid, Cigna, Anthem, United Healthcare Community Plan (AmeriChoice), United Healthcare Empire Plan, Group Health Incorporated (GHI), Aetna Weill Cornell Employee Managed Care Plan, Oxford Health Plans Metro/Core/Charter, Rockefeller University - Trustmark, Aetna Weill Cornell Employee PPO Plan, Amida Care, Oxford Health Plans Freedom, VNSNY CHOICE HMO, Aetna - NYP, VNSNY CHOICE Medicare, Oxford Health Plans Liberty, Aetna-NYP EPO/POS, VNSNY CHOICE and WorldWide Medical.

Insurance Accepted by Provider includes:

According to our sources, Dr. Massimo Cristofanilli, MD accepts the following insurance providers:

Aetna PPO

Health Insurance Plan of New York (HIP)

United Healthcare Medicare

Aetna HMO

Aetna Medicare

EmblemHealth

Fidelis Care

WellCare

Medicare Advantage

Affinity Health Plan

GHI CBP

United Healthcare

Aetna

Oxford Health Plans

Medicare

Healthfirst

Medicaid

Cigna

Anthem

United Healthcare Community Plan (AmeriChoice)

United Healthcare Empire Plan

Group Health Incorporated (GHI)

Aetna Weill Cornell Employee Managed Care Plan

Oxford Health Plans Metro/Core/Charter

Rockefeller University - Trustmark

Aetna Weill Cornell Employee PPO Plan

Amida Care

Oxford Health Plans Freedom

VNSNY CHOICE HMO

Aetna - NYP

VNSNY CHOICE Medicare

Oxford Health Plans Liberty

Aetna-NYP EPO/POS

VNSNY CHOICE

WorldWide Medical

Ratings & Reviews

Dr. Massimo Cristofanilli, MD does not have any reviews yet, be the first to leave a review of Dr. Massimo Cristofanilli, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Massimo Cristofanilli, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Pfizer Inc.	$125,092 IBRANCE $105,692	LORBRENA $8,867	NonCovered Product $670	TALZENNA $89	Non-Covered Product $59	Other $9,715
AstraZeneca UK Limited	$54,244 Truqap $2,000	$52,244
Foundation Medicine, Inc.	$28,000 FOUNDATIONONE $28,000
MENARINI SILICON BIOSYSTEMS, INC.	$27,990 CellSearch $20,875	DEPARRAY $7,115
Merck Sharp & Dohme Corporation	$22,365 KEYTRUDA $22,365
Other	$116,541 KEYTRUDA $13,500	PROSIGNA ASSAY $4,268	IBRANCE $4,175	Truqap $4,172	KISQALI $4,028	Other $86,397

**Types of Payments**
Consulting Fee	$253,368
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$85,430
Travel and Lodging	$13,499
Honoraria	$12,500
Food and Beverage	$9,423
Other	$12

Research Payments

Dr. Massimo Cristofanilli, MD has received 222 research payments totaling $2,532,401.

Biography

Massimo Cristofanilli, MD, is an accomplished board-certified medical oncologist with more than two decades of experience as physician, investigator, researcher and leader. He has demonstrated original and innovative vision in the field of molecular diagnostics, liquid biopsy, translational research and drug development. Additionally, Dr. Cristofanilli has an extensive background in clinical trial design and is a key thought leader in the field of metastatic and locally advanced breast cancer. At Weill Cornell Medicine and NewYork-Presbyterian, Dr. Cristofanilli serves as the Associate Director of Precision Oncology at the Meyer Cancer Center (MCC), and the co-leader of the MCC Breast Cancer Disease Management Team, as well as the Scientific Director of the Englander Institute of Precision Medicine (EIPM). Dr. Cristofanilli received his medical degree from the University “La Sapienza” in Rome with Honors where he subsequently completed his fellowship in medical oncology. He completed an Internal Medicine residency at Cabrini Medical Center in New York and a medical oncology fellowship at The University of Texas MD Anderson Cancer Center, where he also served as Faculty in the Department of Breast Medical Oncology for more than a decade. Dr. Cristofanilli has held several leadership positions over the years, including Chair of Medical Oncology and Associate Director of Clinical Research at the Fox Chase Cancer Center and Associate Director of Translational Research at Thomas Jefferson University. From 2015-2021, Dr. Cristofanilli was Professor of Medicine at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University in Chicago where he also served as the Director of the Breast Disease Team, Director of the Robert Lurie Cancer Center OncoSET Precision Medicine Program, and Associate Director of Clinical Research.In addition to his clinical expertise, Dr. Cristofanilli’s research focuses on biomarkers of endocrine resistance in breast cancer, liquid biopsies and novel drug development. His research in the areas of novel drug development, circulating tumor cells (CTCs) and ctDNA have led to improved treatments for breast cancer. Dr. Cristofanilli is an internationally recognized expert in the research and treatment of Inflammatory Breast Cancer (IBC), the most aggressive and deadly form of breast cancer. He is the founder and President of the IBC International Consortium (IBC-IC). Additionally, Dr. Cristofanilli is globally recognized for his contributions on the detection of micrometastatic disease in breast cancer and a key opinion leader in drug development in hormone-receptor positive metastatic breast cancer. He has co-authored more than 400 peer-reviewed manuscripts.

Select Year:

Dr. Massimo Cristofanilli, MD

Office Locations

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

2013 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2013

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

2014 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2014

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

2015 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2015

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

2016 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2016

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

2017 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2017

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

2018 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2018

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

2019 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2019

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

2020 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2020

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

2021 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2021

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

2022 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2022

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

2023 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2023

Medicare Procedure and Patient Information

2024 Medicare Procedure Volume

2024 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD in 2024

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2024

Average Medicare Patient Data From 2012 - 2024

Average of Total of Conditions of Medicare patients treated by Dr. Massimo Cristofanilli, MD From 2012 - 2024

Education & Training

Insurance Information

Ratings & Reviews

General Payments

Research Payments

Biography

Other Providers in New York, NY